NCATS History

Then-NIH Director Francis S. Collins, M.D., Ph.D., published the founding vision of NCATS on July 6, 2011. Our mission is to support the creation of innovative methods and technologies to speed the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.

Advisory bodies provided guidance and strategic counsel during the development of NCATS:

• Composed of independent experts, a working group of the Advisory Committee to the NIH Director provided input on how NCATS might partner with the private sector and support the translational research enterprise.
• Composed of NIH leadership, the NIH CTSA/NCATS Integration Working Group made recommendations to the NIH Director on how the Clinical and Translational Science Awards (CTSA) Program could be integrated into NCATS.
• Composed of NIH IC Directors (ICD), the ICD-NCATS Working Group made recommendations to the NIH Director about the mission, functions and organization of NCATS.
• The NIH Scientific Management Review Board recommended that NIH create a new translational medicine and therapeutics center. View the December 2010 Report on Translational Medicine and Therapeutics (PDF - 644KB).

Leadership

In September 2012, the NIH Director announced the appointment of Christopher P. Austin, M.D., as director of NCATS. When Austin announced his departure in early 2021, Deputy Director Joni L. Rutter, Ph.D., was selected as acting director. In November 2022, Rutter was selected as director of NCATS.

Learn more about NCATS’ director and read the Director’s Messages, which highlight the center's priorities.

Approach

We are unique in that we focus not on specific diseases, but on what many diseases have in common. Emphasizing the translational science process, we promote three Ds:

• Developing new approaches, technologies, resources and models
• Demonstrating their usefulness
• Disseminating the data, analysis and methodologies to the community

To accomplish the three Ds, the center relies on the power of data, new technologies and teamwork. In this way, we function like an adapter, allowing distinct parts of the research system to connect and collaborate more effectively.

Our approach and mission complement the work of other NIH institutes and centers, the private sector, and the nonprofit community. Collaborations among government, academia, industry and nonprofit patient groups are crucial for successful translation: No organization can succeed alone. To this end, we lead innovative and collaborative approaches in translational science that are crosscutting and useful for the broader scientific community.

Strategic Plan

We developed a strategic plan in 2016 to outline our strategic goals and principles. It is organized into four overarching themes: translational science, collaboration and partnerships, education and training, and stewardship. The themes are captured in the strategic goals and collectively provide an overview of what the center plans to accomplish to achieve its mission.

Learn about our current strategic planning process.

Reports

Annual and biennial reports showcase our translational science initiatives that speed medical research progress and shorten the journey from scientific discovery to better health.

• 2021–2022 (PDF - 2.1MB)
• 2019–2020 (PDF - 3.9MB)
• 2017–2018 (PDF - 2.2MB)
• 2016 (PDF - 3.4MB)
• 2015 (PDF - 3MB)
• 2014 (PDF - 2MB)
• 2012–2013 (PDF - 2MB)

View the NIH Almanac to see more of our program highlights throughout the past decade.

Milestone Anniversaries

We marked our fifth anniversary in 2016 and our 10th anniversary in 2021. 

At the 10-year anniversary, we hosted an event to highlight how the center’s innovative and team science approach addresses unmet needs and to usher in the next decade of bold solutions.

Read more about our impact in advancing translational science.